Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Use of sugammadex is associated with reduced incidence and severity of postoperative nausea and vomiting in adult patients with obesity undergoing laparoscopic bariatric surgery: a post-hoc analysis

Fig. 2

Stacked bar charts showing the severity of PONV (A), PON (B), and POV (C) within 48 h postoperatively between the sugammadex and neostigmine groups. Sug the sugammadex group, Neo the neostigmine group, PONV postoperative nausea and vomiting, PON postoperative nausea, POV postoperative vomiting

Back to article page